Arborcandins A, B, C, D, E and F, novel 1,3-β-glucan synthase inhibitors:: Physico-chemical properties and structure elucidation

被引:5
|
作者
Ohyama, T
Iwadate-Kurihara, Y
Ishikawa, T
Miyakoshi, S
Hamano, K
Inukai, M
机构
[1] Sankyo Co Ltd, Lead Discovery Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Exploratory Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
来源
JOURNAL OF ANTIBIOTICS | 2003年 / 56卷 / 12期
关键词
D O I
10.7164/antibiotics.56.1024
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Arborcandins A, 13, C, D, E and F, which possess potent 1,3-beta-glucan synthase inhibitory activity, were isolated from the cultured broth of a filamentous fungus, strain SANK 17397. The structures of arborcandins A, B, C, D, E and F were elucidated by a combination of NMR and mass spectrometry, and established to be novel cyclic peptides containing uncommon amino acid residues.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [1] Arborcandins A, B, C, D, E and F, novel 1,3-β-glucan synthase inhibitors:: Production and biological activity
    Ohyama, T
    Kurihara, Y
    Ono, Y
    Ishikawa, T
    Miyakoshi, S
    Hamano, K
    Arai, M
    Suzuki, T
    Igari, H
    Suzuki, Y
    Inukai, V
    JOURNAL OF ANTIBIOTICS, 2000, 53 (10): : 1108 - 1116
  • [2] Bisabosquals, novel squalene synthase inhibitors - II. Physico-chemical properties and structure elucidation
    Minagawa, K
    Kouzuki, S
    Nomura, K
    Kawamura, Y
    Tani, H
    Terui, Y
    Nakai, H
    Kamigauchi, T
    JOURNAL OF ANTIBIOTICS, 2001, 54 (11): : 896 - 903
  • [3] Novel 1,3-β-glucan synthase inhibitors
    Tranter, D
    DRUG DISCOVERY TODAY, 2001, 6 (03) : 157 - 158
  • [4] Synthesis and antifungal activities of novel 1,3-β-D-glucan synthase inhibitors.: Part 1
    Masubuchi, K
    Okada, T
    Kohchi, M
    Sakaitani, M
    Mizuguchi, E
    Shirai, H
    Aoki, M
    Watanabe, T
    Kondoh, O
    Yamazaki, T
    Satoh, Y
    Kobayashi, K
    Inoue, T
    Horii, I
    Shimma, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (03) : 395 - 398
  • [5] Terreulactones A, B, C, and D:: Novel acetylcholinesterase inhibitors produced by Aspergillus terreus -: II.: Physico-chemical properties and structure determination
    Kim, WG
    Cho, KM
    Lee, CK
    Yoo, ID
    JOURNAL OF ANTIBIOTICS, 2003, 56 (04): : 351 - 357
  • [6] Melanocins A, B and C, new melanin synthesis inhibitors produced by Eupenicillium shearii -: II.: Physico-chemical properties and structure elucidation
    Kim, JP
    Kim, BY
    Yun, BS
    Ryoo, IJ
    Lee, IK
    Kim, WG
    Pyun, YR
    Yoo, ID
    JOURNAL OF ANTIBIOTICS, 2003, 56 (12): : 1000 - 1003
  • [7] Synthesis and antifungal activities of novel 1,3-β-D-glucan synthase inhibitors.: Part 2
    Masubuchi, K
    Okada, T
    Kohchi, M
    Murata, T
    Tsukazaki, M
    Kondoh, O
    Yamazaki, T
    Satoh, Y
    Ono, Y
    Tsukaguchi, T
    Kobayashi, K
    Ono, N
    Inoue, T
    Horii, I
    Shimma, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (10) : 1273 - 1276
  • [8] Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors
    Onishi, J
    Meinz, M
    Thompson, J
    Curotto, J
    Dreikorn, S
    Rosenbach, M
    Douglas, C
    Abruzzo, G
    Flattery, A
    Kong, L
    Cabello, A
    Vicente, F
    Pelaez, F
    Diez, MT
    Martin, I
    Bills, G
    Giacobbe, R
    Dombrowski, A
    Schwartz, R
    Morris, S
    Harris, G
    Tsipouras, A
    Wilson, K
    Kurtz, MB
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 368 - 377
  • [9] SHISEN-1,a novel phenazine antibiotic from Streptoplanospora viridis Ⅱ.Physico-chemical properties and structure elucidation
    岳宏飞
    陈永乐
    中国抗生素杂志, 1998, (02) : 30+32+34+31+33 - 30+32+34+31+33
  • [10] Piperazine propanol derivative as a novel antifungal targeting 1,3-β-D-glucan synthase
    Kondoh, O
    Inagaki, Y
    Fukuda, H
    Mizuguchi, E
    Ohya, Y
    Arisawa, M
    Shimma, N
    Aoki, Y
    Sakaitani, M
    Watanabe, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (11) : 2138 - 2141